Fibronectin within Sodium Alginate Microcapsules Improved Osteogenic Differentiation of BMMSCs in Dose Dependent Manner by Targeting SP7, OCN, CDK1, ZBTB16, and Twist1 Expression

Fibronectin within Sodium Alginate Microcapsules Improved Osteogenic Differentiation of BMMSCs in Dose Dependent Manner by Targeting SP7, OCN, CDK1, ZBTB16, and Twist1 Expression


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: بابک نجاتی , پروین اکبرزاده لاله , کریم شمس اسنجان , مهسا محمدی

کلمات کلیدی: Bone marrow-derived MSCs (BMMSCs), Alginate, Fibronectin, Microcapsules, Osteogenic differentiation

نشریه: 951 , 1 , 12 , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله کریم شمس اسنجان
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ایمونولوژی
کد مقاله 78562
عنوان فارسی مقاله Fibronectin within Sodium Alginate Microcapsules Improved Osteogenic Differentiation of BMMSCs in Dose Dependent Manner by Targeting SP7, OCN, CDK1, ZBTB16, and Twist1 Expression
عنوان لاتین مقاله Fibronectin within Sodium Alginate Microcapsules Improved Osteogenic Differentiation of BMMSCs in Dose Dependent Manner by Targeting SP7, OCN, CDK1, ZBTB16, and Twist1 Expression
ناشر 6
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Abstract Purpose: Insoluble fibronectin as an extracellular matrix (ECM) protein has the potential topromote proliferation, differentiation, and migration of mesenchymal stem cells (MSCs).However, there is limited information about the effects of fibronectin various concentrations onbone marrow-derived MSCs (BMMSCs) function and differentiationMethods: In this experimental study, using a gel injection device, BMMSCs were encapsulatedin sodium alginate microcapsules containing 1.25% alginate, 1% gelatin, and fibronectin (0.01,0.05, 0.1, and 0.2 μg/ml). MTT assay was used to examine the proliferation of BMMSCs. Also,BMMSCs apoptosis were analyzed using Annexin-V/PI staining and fluorescence activated cellsorting (FACS). Alkaline phosphatase (ALP) test was conducted to assess BMMSCs osteogenicdifferentiation potential. Finally, mRNA expression levels of the SP7, osteocalcin (OCN), TwistFamily BHLH Transcription Factor 1 (Twist1), Peroxisome proliferator‐activated receptor γ2(PPARγ2), Cyclin-dependent kinase 1 (CDK1), and Zinc Finger and BTB Domain Containing 16(ZBTB16), following exposure with fibronectin 0.1 μg/ml.Results: According to results, fibronectin had the potential to promote proliferation rates of theBMMSCs, in particular at 0.1 and 0.2 μg/ml concentrations. we showed that the fibronectinwas not able to modify apoptosis rates of the BMMSCs. ALP test results approved the notablepotential of the fibronectin, to trigger osteogenic differentiation of the BMMSCs. Also, RT-PCRresults indicated that fibronectin 0.1 μg/ml could augment osteogenic differentiation of culturedBMMSCs through targeting of OCN, SP7, Twist1, CDK1, and ZBTB16, strongly or slightly.Conclusion: Results showed that fibronectin can improve proliferation and osteogenicdifferentiation of BMMSCs without any effect on these cells’ survival.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
بابک نجاتیششم
پروین اکبرزاده لالهچهارم
کریم شمس اسنجاناول
مهسا محمدیسوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
apb-12-109.pdf1401/02/043058898دانلود